AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33690909 — intervention group
Group type: COMPARATOR
Intervention: Control cream
Number of subjects: 60
Study 33690909 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioning exposure
Number of subjects: 60
Study 33690909 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo disclosure
Number of subjects: 60
Study 32007996 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise snacks (6 × 1 min of resistance‐based activities) 3 times daily for 3 months with glutamine (0.5 g/kg/day)
Number of subjects: 12
Study 32007996 — intervention group
Group type: COMPARATOR
Intervention: Exercise snacks (6 × 1 min of resistance‐based activities) 3 times daily for 3 months with placebo
Number of subjects: 12
Study 32007996 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise snacks (6 × 1 min of resistance‐based activities)
Number of subjects: 12
Study 37833132 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed Suctioning System (CSS)
Number of subjects: 100
Study 37833132 — intervention group
Group type: COMPARATOR
Intervention: Open Suctioning System (OSS)
Number of subjects: 100
Study 33411466 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin monotherapy
Number of subjects: 1234
Study 33411466 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin and aminoglycoside therapy
Number of subjects: 1234
Study 33411466 — intervention group
Group type: COMPARATOR
Intervention: Piperacillin/tazobactam
Number of subjects: 1234
Study 34921690 — intervention group
Group type: EXPERIMENTAL
Intervention: Static computer-aided implant surgery (s-CAIS)
Number of subjects: 40
Study 34921690 — intervention group
Group type: COMPARATOR
Intervention: Conventional implant surgery (CIS)
Number of subjects: 40
Study 34921690 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 40
Study 33430772 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg IVI in 100 ml normal saline (D group)
Number of subjects: 110
Study 33430772 — intervention group
Group type: COMPARATOR
Intervention: Placebo (C group)
Number of subjects: 110
Study 35931071 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task cognitive-motor training (DTT)
Number of subjects: 68
Study 35931071 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-task cognitive training (STT)
Number of subjects: 68
Study 35931071 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 68
Study 32071431 — intervention group
Group type: EXPERIMENTAL
Intervention: 6xFCR (fludarabine, cyclophosphamide, and rituximab)
Number of subjects: 201
Study 32071431 — intervention group
Group type: COMPARATOR
Intervention: Watch and wait (standard of care)
Number of subjects: 201
Study 32089252 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% litchi serum
Number of subjects: 29
Study 32089252 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% litchi serum
Number of subjects: 29
Study 32089252 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 34324113 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-mastectomy radiation therapy (PMRT)
Number of subjects: 940
Study 34324113 — intervention group
Group type: COMPARATOR
Intervention: No post-mastectomy radiation therapy (no PMRT)
Number of subjects: 940
Study 33029683 — intervention group
Group type: EXPERIMENTAL
Intervention: Video discharge instructions (VDIs)
Number of subjects: 139
Study 33029683 — intervention group
Group type: COMPARATOR
Intervention: Usual verbal instructions
Number of subjects: 139
Study 35306919 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple Continuous (SC) suture pattern
Number of subjects: 35
Study 35306919 — intervention group
Group type: COMPARATOR
Intervention: Simple Interrupted (SI) suture pattern
Number of subjects: 35
Study 34245768 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine growth restriction (IUGR)
Number of subjects: 314
Study 34245768 — intervention group
Group type: COMPARATOR
Intervention: Appropriate for gestational age (AGA)
Number of subjects: 314
Study 32921065 — intervention group
Group type: EXPERIMENTAL
Intervention: External application of internal expulsion pus‐expelling decoction (IEPED) combined with surgery
Number of subjects: 110
Study 32921065 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment with IEPED)
Number of subjects: 110
Study 32921065 — intervention group
Group type: EXPERIMENTAL
Intervention: External application of IEPED
Number of subjects: 110
Study 35552050 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized nutritional support
Number of subjects: 1866
Study 35552050 — intervention group
Group type: COMPARATOR
Intervention: Usual care nutrition
Number of subjects: 1866
Study 35552050 — intervention group
Group type: EXPERIMENTAL
Intervention: NRS 2002
Number of subjects: 1866
Study 35552050 — intervention group
Group type: EXPERIMENTAL
Intervention: SGA
Number of subjects: 1866
Study 35552050 — intervention group
Group type: EXPERIMENTAL
Intervention: MNA
Number of subjects: 1866
Study 35552050 — intervention group
Group type: EXPERIMENTAL
Intervention: SNAQ
Number of subjects: 1866
Study 35552050 — intervention group
Group type: EXPERIMENTAL
Intervention: MUST
Number of subjects: 1866
Study 34057649 — intervention group
Group type: EXPERIMENTAL
Intervention: smartphone-based pain management application
Number of subjects: 192
Study 34057649 — intervention group
Group type: COMPARATOR
Intervention: face-to-face pain management program
Number of subjects: 192
Study 32438250 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunocastration
Number of subjects: 10
Study 32438250 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic suspension
Number of subjects: 10
Study 32438250 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet ageing
Number of subjects: 10
Study 32438250 — intervention group
Group type: COMPARATOR
Intervention: Control (Intact males)
Number of subjects: 10
Study 34238835 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference-sensitive instrument for shared decision-making
Number of subjects: 46
Study 34238835 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared Decision-Making Questionnaire
Number of subjects: 46
Study 34238835 — intervention group
Group type: COMPARATOR
Intervention: Gynecologists' application of the instrument
Number of subjects: 46
Study 33196101 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose reduction strategy for adalimumab, etanercept and ustekinumab
Number of subjects: 0
Study 33196101 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study 33172225 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg (Group 2)
Number of subjects: 60
Study 33172225 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Group 1)
Number of subjects: 60
Study 32061400 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 mg methylprednisolone
Number of subjects: 40
Study 32061400 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 34078432 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-hour educational programme in situation awareness
Number of subjects: 20
Study 34078432 — intervention group
Group type: COMPARATOR
Intervention: Training without education in situation awareness (Control)
Number of subjects: 20
Study 32221496 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-visual presentation and written information in the format of mind maps
Number of subjects: 93
Study 32221496 — intervention group
Group type: COMPARATOR
Intervention: Audio-visual presentation and written information in the format of leaflets from British Orthodontic Society
Number of subjects: 93
Study 32221496 — intervention group
Group type: COMPARATOR
Intervention: Audio-visual presentation and written information in the format of generic mind map
Number of subjects: 93
Study 35428982 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE‐083 240 mg/muscle injected bilaterally every 3 weeks in the biceps brachii (BB) muscles
Number of subjects: 58
Study 35428982 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE‐083 240 mg/muscle injected bilaterally every 3 weeks in the tibialis anterior (TA) muscles
Number of subjects: 58
Study 35428982 — intervention group
Group type: COMPARATOR
Intervention: Placebo injected bilaterally every 3 weeks in the biceps brachii (BB) muscles
Number of subjects: 58
Study 35428982 — intervention group
Group type: COMPARATOR
Intervention: Placebo injected bilaterally every 3 weeks in the tibialis anterior (TA) muscles
Number of subjects: 58
Study 33769358 — intervention group
Group type: EXPERIMENTAL
Intervention: Early phacoemulsification
Number of subjects: 62
Study 33769358 — intervention group
Group type: COMPARATOR
Intervention: Laser peripheral iridotomy (LPI)
Number of subjects: 62
Study 32337698 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA)
Number of subjects: 96
Study 32337698 — intervention group
Group type: COMPARATOR
Intervention: Mosapride control (MC)
Number of subjects: 96
Study 32337698 — intervention group
Group type: COMPARATOR
Intervention: Sham EA & Mosapride (MS)
Number of subjects: 96
Study 35057416 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium phosphate (SP) supplementation (50 mg·kg−1 of FFM/day)
Number of subjects: 24
Study 35057416 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium phosphate (SP) supplementation
Number of subjects: 24
Study 35057416 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 32291309 — intervention group
Group type: EXPERIMENTAL
Intervention: HFNC at 60 L/min
Number of subjects: 10
Study 32291309 — intervention group
Group type: EXPERIMENTAL
Intervention: HFNC at 40 L/min
Number of subjects: 10
Study 32291309 — intervention group
Group type: COMPARATOR
Intervention: Baseline (no therapy)
Number of subjects: 10
Study 32291309 — intervention group
Group type: EXPERIMENTAL
Intervention: HFNC (20, 40, and 60 L/min)
Number of subjects: 10
Study 32291309 — intervention group
Group type: COMPARATOR
Intervention: Conventional nasal prongs at 5 L/min
Number of subjects: 10
Study 35326369 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU + MCT
Number of subjects: 100
Study 35326369 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 100
Study 33925633 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 billion CFU of a multi-strain probiotic
Number of subjects: 14
Study 33925633 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 34496930 — intervention group
Group type: EXPERIMENTAL
Intervention: Teletrial model for recruitment
Number of subjects: 0
Study 34496930 — intervention group
Group type: COMPARATOR
Intervention: Traditional recruitment methods (not explicitly mentioned but implied as control)
Number of subjects: 0
Study 32415981 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery from hyponatraemia
Number of subjects: 118
Study 32415981 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in serum sodium level at day 4
Number of subjects: 118
Study 32415981 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in serum sodium level at day 7
Number of subjects: 118
Study 32415981 — intervention group
Group type: COMPARATOR
Intervention: Baseline hyponatraemia
Number of subjects: 118
Study 32415981 — intervention group
Group type: COMPARATOR
Intervention: Baseline serum sodium level
Number of subjects: 118
Study 35587462 — intervention group
Group type: EXPERIMENTAL
Intervention: Video with male narrator
Number of subjects: 0
Study 35587462 — intervention group
Group type: EXPERIMENTAL
Intervention: Video with female narrator
Number of subjects: 0
Study 35587462 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcript of the video
Number of subjects: 0
Study 35587462 — intervention group
Group type: COMPARATOR
Intervention: No information (control group)
Number of subjects: 0
Study 34019483 — intervention group
Group type: EXPERIMENTAL
Intervention: CAU plus one dose of 0.1 mg/kg oral ondansetron
Number of subjects: 194
Study 34019483 — intervention group
Group type: COMPARATOR
Intervention: CAU (oral rehydration therapy)
Number of subjects: 194
Study 34941339 — intervention group
Group type: EXPERIMENTAL
Intervention: Life Review Therapy (LRT-HS), approximately 20 sessions including structured life review, narrative exposure, cognitive and behavioral elements.
Number of subjects: 2
Study 34231281 — intervention group
Group type: EXPERIMENTAL
Intervention: EscharEx
Number of subjects: 73
Study 34231281 — intervention group
Group type: COMPARATOR
Intervention: gel vehicle
Number of subjects: 73
Study 35410322 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen treatment
Number of subjects: 20
Study 35410322 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol treatment
Number of subjects: 20
Study 34014688 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational enhancement and cognitive behavioral therapies plus adjunctive pharmacotherapy
Number of subjects: 65
Study 34014688 — intervention group
Group type: COMPARATOR
Intervention: Motivational enhancement and cognitive behavioral therapies plus placebo
Number of subjects: 65
Study 34014688 — intervention group
Group type: EXPERIMENTAL
Intervention: Time with cannabis‐using friends and siblings
Number of subjects: 65
Study 34014688 — intervention group
Group type: EXPERIMENTAL
Intervention: Time with parents or non‐using siblings
Number of subjects: 65
Study 32057088 — intervention group
Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 40
Study 32057088 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 40
Study 35782469 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine hesitancy due to misinformation, conspiracies, myths, and rumors about side effects of vaccination.
Number of subjects: 17
Study 35782469 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital media as a primary source of information regarding vaccination.
Number of subjects: 17
Study 35782469 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare system uncertainty.
Number of subjects: 17
Study 32397850 — intervention group
Group type: EXPERIMENTAL
Intervention: BBR plus bezafibrate
Number of subjects: 36
Study 32397850 — intervention group
Group type: EXPERIMENTAL
Intervention: Bezafibrate
Number of subjects: 36
Study 32397850 — intervention group
Group type: EXPERIMENTAL
Intervention: BBR
Number of subjects: 36
Study 32997900 — intervention group
Group type: EXPERIMENTAL
Intervention: Faster R‐CNN nomogram for predicting metastatic LN status
Number of subjects: 545
Study 32997900 — intervention group
Group type: EXPERIMENTAL
Intervention: Faster R‐CNN nomogram for predicting LN metastasis degree
Number of subjects: 545
Study 32997900 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibration plots and decision curve analyses
Number of subjects: 545
Study 34905152 — intervention group
Group type: EXPERIMENTAL
Intervention: 2D‐STE analysis in DMD group
Number of subjects: 25
Study 32513144 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomic nomogram incorporating radiomic signature and conventional CT signs
Number of subjects: 210
Study 32513144 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomic signature consisting of five radiomic features
Number of subjects: 210
Study 32513144 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional CT signs
Number of subjects: 210
Study 34056868 — intervention group
Group type: EXPERIMENTAL
Intervention: MDASS (Mindsets of Depression, Anxiety, and Stress Scale)
Number of subjects: 1735
Study 34056868 — intervention group
Group type: EXPERIMENTAL
Intervention: MDASS with reversed items
Number of subjects: 1735
Study 32898050 — intervention group
Group type: EXPERIMENTAL
Intervention: Strenuous exercise (≥90 minutes per week)
Number of subjects: 351
Study 32898050 — intervention group
Group type: COMPARATOR
Intervention: Less active (exercised less than 90 minutes per week)
Number of subjects: 351
Study 32898050 — intervention group
Group type: COMPARATOR
Intervention: Comparison of activity levels
Number of subjects: 351
Study 32049857 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion treatment (14 sessions over 2 weeks) with anti-depressant treatment
Number of subjects: 176
Study 32049857 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group receiving only anti-depressant treatment
Number of subjects: 176
Study 35672690 — intervention group
Group type: EXPERIMENTAL
Intervention: liposomal MTP-PE alone
Number of subjects: 8
Study 35672690 — intervention group
Group type: EXPERIMENTAL
Intervention: liposomal MTP-PE in combination with ifosfamide
Number of subjects: 8
Study 32732229 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal disinfection at 70°C and 50% relative humidity for 60 minutes
Number of subjects: 4
Study 32732229 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal disinfection at 70°C and 50% relative humidity
Number of subjects: 4
Study 32732229 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple cycles of thermal disinfection
Number of subjects: 4
Study 32732229 — intervention group
Group type: COMPARATOR
Intervention: Untreated inoculated control masks
Number of subjects: 4
Study 35548071 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-child relationship score
Number of subjects: 485
Study 35548071 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental Stress Scale
Number of subjects: 485
Study 35548071 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived Parental Aggression Scale
Number of subjects: 485
Study 34070315 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body electromyostimulation (WB-EMS)
Number of subjects: 54
Study 34070315 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 54
Study 33033844 — intervention group
Group type: EXPERIMENTAL
Intervention: New face mask
Number of subjects: 10
Study 33033844 — intervention group
Group type: COMPARATOR
Intervention: Conventional face mask
Number of subjects: 10
Study 36253042 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional relaxation (FR) therapy, implemented as group therapy, 12 sessions led by a certified physiotherapist once a week.
Number of subjects: 270
Study 36253042 — intervention group
Group type: COMPARATOR
Intervention: Placebo relaxation intervention for the same duration as the FR therapy.
Number of subjects: 270
Study 36253042 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional relaxation (FR) therapy
Number of subjects: 270
Study 32030417 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg/day
Number of subjects: 4300
Study 32030417 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4300
Study 35000236 — intervention group
Group type: EXPERIMENTAL
Intervention: ritlecitinib
Number of subjects: 142
Study 35000236 — intervention group
Group type: EXPERIMENTAL
Intervention: brepocitinib
Number of subjects: 142
Study 35000236 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 142
Study 35000236 — intervention group
Group type: EXPERIMENTAL
Intervention: AASIS and SALT scores correlation
Number of subjects: 142
Study 33998296 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamification with collaboration
Number of subjects: 553
Study 33998296 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 553
Study 33998296 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamification with support
Number of subjects: 553
Study 33998296 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamification with competition
Number of subjects: 553
Study 35679461 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional endodontic access cavity design
Number of subjects: 148
Study 35679461 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hypochlorite solution (5.25%)
Number of subjects: 148
Study 35679461 — intervention group
Group type: EXPERIMENTAL
Intervention: Gel-based formulation of sodium hypochlorite
Number of subjects: 148
Study 35679461 — intervention group
Group type: EXPERIMENTAL
Intervention: Distilled water
Number of subjects: 148
Study 35679461 — intervention group
Group type: COMPARATOR
Intervention: Conservative endodontic access cavity design
Number of subjects: 148
Study 35795100 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided paravertebral block (PVB) followed by sufentanil patient-controlled intravenous analgesia (PCIA)
Number of subjects: 80
Study 35795100 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil patient-controlled intravenous analgesia (PCIA) only
Number of subjects: 80
Study 32350909 — intervention group
Group type: EXPERIMENTAL
Intervention: ixazomib plus lenalidomide-dexamethasone (IRd)
Number of subjects: 722
Study 32350909 — intervention group
Group type: COMPARATOR
Intervention: placebo plus lenalidomide-dexamethasone (placebo-Rd)
Number of subjects: 722
Study 35251438 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (10 weekly sessions of manual Acupuncture)
Number of subjects: 0
Study 35251438 — intervention group
Group type: COMPARATOR
Intervention: Sham Acupuncture (10 weekly sessions of Sham Acupuncture)
Number of subjects: 0
Study 35251438 — intervention group
Group type: COMPARATOR
Intervention: Wait-List Control (10 weeks on a Wait-List)
Number of subjects: 0
Study 34157053 — intervention group
Group type: EXPERIMENTAL
Intervention: DSEQ (Digital-Screen Exposure Questionnaire)
Number of subjects: 400
Study 34157053 — intervention group
Group type: EXPERIMENTAL
Intervention: DSEQ
Number of subjects: 400
Study 34999679 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (ORS, zinc plus probiotics)
Number of subjects: 500
Study 34999679 — intervention group
Group type: COMPARATOR
Intervention: Placebo (ORS, zinc plus placebo)
Number of subjects: 500
Study 32094013 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Superior (DS) approach
Number of subjects: 5341
Study 32094013 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Anterior (DA) approach
Number of subjects: 5341
Study 32094013 — intervention group
Group type: COMPARATOR
Intervention: Posterolateral (PL) approach
Number of subjects: 5341
Study 35220180 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block (ESPB)
Number of subjects: 90
Study 35220180 — intervention group
Group type: EXPERIMENTAL
Intervention: Pectoserratus Plane Block (PSPB)
Number of subjects: 90
Study 35220180 — intervention group
Group type: COMPARATOR
Intervention: Control group (received intravenous tenoxicam and paracetamol, with morphine via patient‐controlled analgesia)
Number of subjects: 90
Study 32000786 — intervention group
Group type: EXPERIMENTAL
Intervention: House characteristics (presence of screens on windows, possession of LLINs)
Number of subjects: 467
Study 32000786 — intervention group
Group type: EXPERIMENTAL
Intervention: House characteristics (opened eaves, high number of windows, presence of holes in walls, living close to breeding sites)
Number of subjects: 467
Study 32000786 — intervention group
Group type: EXPERIMENTAL
Intervention: Anopheles gambiae s.l. tested by ELISA
Number of subjects: 467